Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 160

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 160
---
 addition to the base rent of $5,000 per month to be paid by the Company to BST the Company shall also reimburse BST for any and all shared expenses as such term is defined within the original lease agreement by and between BST and CIF LaMesa LLP beginning January 1, 2024..

BST Partners is controlled by David Koos who serves as the sole officer and director of Regen Biopharma, Inc.

$1,708 lent to the Company by David Koos, the Company’s sole Board Member and Officer, is due and payable at the demand of the holder and bears simple interest at a rate of 15% per annum.

$15,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on May 3. 2025 and bears simple interest at a rate of 10% per annum.

$25,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on June 5. 2025 and bears simple interest at a rate of 10% per annum.

Zander Therapeutics, Inc. and the Company are under common control.

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

Subsequent to the original issuance of Regen’s annual unaudited financial statements for the year ended September 30, 2024 the Company determined that the following revisions are required

The value given to 249,915 common shares issued as nonemployee compensation has been adjusted to $0.1499 per share

The market price utilized in calculating Derivative Liability as of September 30, 2024 has been corrected to $0.1027 per share.

$204,847 in Unrealized Losses on Investment Securities has been reclassified as Other Comprehensive Income

<div align='center'>120</div>

Cumulative Effect of Restatement of Previously Issued Financial Statements for the Year ended September 30, 2024:

<div align='center'>REGEN BIOPHARMA , INC.

CONSOLIDATED BALANCE SHEETS</div>

|                                                                                                                                       |     | Originally Presented | As of September 30, 2024 |   |     |     | Adjustments |   |     | Restated | As of September 30, 2024 |   |
|:--------------------------------------------------------------------------------------------------------------------------------------|:----|:---------------------|-------------------------:|:--|:----|:----|------------:|:--|:----|:---------|-------------------------:|:--|
| AS